Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Identifies unresolved aspects of cAMP-mediated platelet inhibition; leaves open mechanistic questions for targeted future research.
Blood platelet activation must be tightly regulated to ensure a balance between haemostasis and thrombosis. The cAMP signalling pathway is the most powerful endogenous regulator of blood platelet activation. PKA (protein kinase A), the foremost effector of cAMP signalling in platelets, phosphorylates a number of proteins that are thought to modulate multiple aspects of platelet activation. In the present mini-review, we outline our current understanding of cAMP-mediated platelet inhibition and discuss some of the issues that require clarification.
No takes yet. Share an insight, caveat, or question.
Raslan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: